Category: Japan

Chairman of Tokyo Metropolitan Medical Association Declares During Surge, Time for Ivermectin is Now

In Dr. Ozaki’s recent speech, he declared that ivermectin has demonstrated significant benefits in reducing infections and deaths where the regimen is prophylactically administered for another indication. The head of the Metropolitan Medical Association declared that while clinical trials were important, it was time to greenlight doctors to prescribe ivermectin in association with giving the patient informed consent.

Read More »

Front Line COVID-19 Critical Care Alliance Statement – Weak Guidance on Ivermectin from the World Health Organization (WHO)

“I am deeply troubled that the WHO made this hasty decision on guidance before reviewing all available data,” said Pierre Kory, MD, MPH, president and chief medical officer of the FLCCC.
“Their recommendation ignores the evidence, creates more controversy, and will only lead to continuing suffering and death from COVID-19. There are now over 24 randomized trials results
that have been reported to the Unitaid/WHO team yet todays guidance was inexcusably based on a faulty analysis of just 16 of the available trials. Further, these erroneous findings directly conflict
with numerous other peer-reviewed expert analyses that have found the data overwhelmingly demonstrates that ivermectin saves lives from COVID-19. There is no reason not to recommend it
for everyone as a safe drug for prevention and treatment.”

Read More »

Censorship Kills: The Shunning of a COVID Therapeutic

The science shows that ivermectin works. Over 40 randomized trials and observational studies from around the world attest to its efficacy against the novel coronavirus. Meta-analyses by four separate research groups, including ours, found an average reduction in mortality of between 68%-75%. And 10 of 13 randomized controlled trials found statistically significant reductions in time to viral clearance, an effect not associated with any other COVID-19 therapeutic. Furthermore, ivermectin has an unparalleled safety record and low cost, which should negate any fears or resistance to immediate adoption.

Read More »

Analysis of the predictive factors for critical illness of COVID-19 during treatment – Relationship between serum zinc level and critical illness of COVID-19

Source: Science Direct Author links YukakoYasuiaHiroyukiYasuibKumikoSuzukicTakakoSaitoucYoshikiYamamotoaToshihikoIshizakaaKoujiNishidadShingoYoshiharaeIwaoGohmadYoshihikoOgawae aDepartment of Pharmacy, Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai City, Osaka, 593-8304, Japan bDepartment of Analytical &

Read More »